SVP Clinical Development Jeffrey Wiezorek sold $152K of Kite Pharma, Inc.

Sold$151,949

$50.65Price

3,000Shares

−17%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Tue, May 31. Filed Thu, Jun 2, 1:15 PM ET, during the session. Not investment advice.